Clinical trial
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms…
NCT00318500 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00318500 |
|---|---|
| Title | Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 75 mg and 150 mg Doses of ERB-041 on the Reduction of Symptoms Associated With Endometriosis During Treatment and Post Treatment in Reproductive-Aged Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dysmenorrhea, Dyspareunia, Endometriosis, Pelvic Pain |
| Intervention type | Drug |
| Interventions | ERB-041 |
| Enrollment | 150 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Apr 26, 2006 |
| Last update posted | Dec 10, 2007 |
| Countries | Australia, Belgium, Canada, Hong Kong, South Africa, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: